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Abstract
How cells ensure correct metallation of a given protein and whether a degree of promiscuity in
metal binding has evolved are largely unanswered questions. In a classic case, iron- and
manganese-dependent superoxide dismutases (SODs) catalyze the disproportionation of
superoxide using highly similar protein scaffolds and nearly identical active sites. However, most
of these enzymes are active with only one metal, although both metals can bind in vitro and in
vivo. Iron(II) and manganese(II) bind weakly to most proteins and possess similar coordination
preferences. Their distinct redox properties suggest that they are unlikely to be interchangeable in
biological systems except when they function in Lewis acid catalytic roles, yet recent work
suggests this is not always the case. This review summarizes the diversity of ways in which iron
and manganese are substituted in similar or identical protein frameworks. As models, we discuss
(1) enzymes, such as epimerases, thought to use FeII as a Lewis acid under normal growth
conditions but which switch to MnII under oxidative stress; (2) extradiol dioxygenases, which
have been found to use both FeII and MnII, the redox role of which in catalysis remains to be
elucidated; (3) SODs, which use redox chemistry and are generally metal-specific; and (4) the
class I ribonucleotide reductases (RNRs), which have evolved unique biosynthetic pathways to
control metallation. The primary focus is the class Ib RNRs, which can catalyze formation of a
stable radical on a tyrosine residue in their β2 subunits using either a di-iron or a recently
characterized dimanganese cofactor. The physiological roles of enzymes that can switch between
iron and manganese cofactors are discussed, as are insights obtained from the studies of many
groups regarding iron and manganese homeostasis and the divergent and convergent strategies
organisms use for control of protein metallation. We propose that, in many of the systems
discussed, “discrimination” between metals is not performed by the protein itself, but it is instead
determined by the environment in which the protein is expressed.
Introduction
Mismetallation in vitro
Biochemical work often relies on the overexpression of a protein of interest in a
heterologous host, usually Escherichia coli, grown under “standard” laboratory conditions in
iron-rich media. When the protein requires a metal for activity, insertion of the correct metal
depends on the protein’s affinity for and selectivity between metals available in the cell
†Current address: Department of Chemistry, University of California,
NIH Public Access
Author Manuscript
Metallomics. Author manuscript; available in PMC 2013 October 01.
Published in final edited form as:
Metallomics. 2012 October 1; 4(10): 1020–1036. doi:10.1039/c2mt20142a.
$watermark-text
$watermark-text
$watermark-text
during or after folding, the cellular concentrations of the metals and the protein,1–3 and in
some cases, the presence of cofactor biosynthetic machinery specific to the metal and/or
protein. Proteins overexpressed are often isolated with the incorrect metal (mismetallated)4
or, if the biosynthetic machinery is not up-regulated or if the metal is weakly bound, they
can be isolated predominantly in their apo form (no metal bound). Iron–sulfur clusters,5,6 the
complex cofactors of nitrogenases7 and hydrogenases,8,9 hemes,10 cobalamins,11 and the
dimanganese(III)-tyrosyl radical (MnIII 2-Y•) cofactor12,13 of the class Ib ribonucleotide
reductases (RNRs) are a few examples of cofactors demonstrated to require biosynthetic
machinery for assembly.
Apo-proteins are catalytically inactive. More insidiously, a mismetallated protein may retain
some biological activity. Because, in general, proteins are not isolated from their
endogenous organisms under endogenous levels of expression, their actual catalytic activity
is not known. There are myriad examples in which a correlation of metal with catalytic
activity has been elusive: peptide deformylase,14,15 calprotectin,16 particulate methane
monooxygenase (MMO),17,18 the arylamine-N-oxygenase AurF,19,20 some Mn– and Fe–
superoxide dismutases (SODs),21,22 and the class Ib12 and Ic23 RNRs. Furthermore, many
metallocofactors can self-assemble in vitro with some degree of success from apo-protein
and a metal source, even when biosynthetic pathways are utilized in vivo. Thus, comparison
of activities of apo-protein reconstituted in vitro with various metals provides insight into
candidate metals for in vivo relevance; however, the metal that confers the highest activity is
not necessarily the physiologically relevant cofactor. Ultimately, understanding the cellular
context in which a given protein is expressed is crucial to the correct assignment of the
cofactor.
In this review, we consider these general issues in the specific context of the interplay of Mn
and Fe in biological systems. Of the first row transition metals used commonly by biology
(Mn, Fe, Co, Ni, Cu, and Zn), MnII and FeII generally bind most weakly to proteins and
prefer similar coordination environments, making it difficult for proteins to distinguish
between them on the basis of structure alone. At the same time, the midpoint potentials for
the +III/+II couples of the hexaaquo MnII and FeII ions are 1.5 and 0.8 V (vs. NHE),24
respectively, making the redox chemistry of the two metals far from interchangeable. A
growing body of evidence suggests that aerobic organisms have exploited the similar and
dissimilar properties of these two metals in ingenious ways to protect themselves from
oxidative damage and iron deprivation, frequently encountered in their normal habitats. In
some cases, the substitution of Fe with Mn can occur in the same polypeptide; in others,
separate Mn- and Fe-dependent enzymes are used. In each case, the Fe and Mn binding sites
are nearly identical (Fig. 1). Here we examine four increasingly complex examples of this
ingenuity (reactions shown in Fig. 2): (1) enzymes that use FeII or MnII interchangeably as a
Lewis acid catalyst;25 (2) FeII- and MnII-containing extradiol dioxygenases,26,27 such as
homoprotocatechuate 2,3-dioxygenase (HPCD), which catalyze a redox reaction but for
which the involvement of the metal ions in a redox role is unresolved; (3) Fe– and Mn–
SODs, which cycle their mononuclear metal cofactors between +II and +III states to
disproportionate O2•−;28 and (4) the class I ribonucleotide reductases (RNRs), which use
diiron, dimanganese, and manganese–iron cofactors29,30 to generate a stable protein- or
metal-based radical cofactor essential for deoxynucleotide formation in all eukaryotes and
most aerobic prokaryotes. We focus mainly on the class I RNRs because they beautifully
illustrate the challenges of identifying a physiological metallocofactor, the utility of parallel
in vitro and in vivo studies in this determination, and the adaptations Nature must make to
accommodate the chemical differences between manganese and iron in redox reactions.
By consideration of these specific systems, we hope to provide general insight into how an
experimentalist identifies the physiologically relevant cofactor of a metalloprotein and how
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this information sheds light on the mechanism(s) by which the organism ensures that
protein’s correct metallation. As will become apparent, these studies are in their relative
infancy, and much more data needs to be collected before a general model can emerge.
However, in our view, the results to date can be accounted for most simply, in the case of
prokaryotes at least, by a model in which a protein’s ability to discriminate between iron and
manganese is chiefly dictated by metal availability, rather than a structural preference of that
protein for FeII or MnII. Metal availability, in turn, is determined by how the organism tunes
its overall metal homeostatic machinery. Therefore, it is likely that the metallation of many
of these enzymes that can be activated with either Mn or Fe will be chiefly governed within
a given organism by the conditions in which the protein is expressed. Whether this is the
only, or the primary, mechanism remains to be determined.
Mismetallation in vivo
Mismetallation is not only a problem when proteins are present at non-physiological levels
in non-physiological growth conditions; it is also a challenge for organisms during routine
growth. While some “mismetallated” enzymes may retain activity, others are inactive.
Cellular metal ion homeostasis must be managed carefully because cells use a variety of
metals, because certain transition metals (chiefly FeII and CuI) can react with O2 to produce
reductive metabolites of O2 that are damaging to cells,37 and because a given protein can
bind many metals and the tightest binding metal is often not the “correct” one required for
function. To ensure that the correct metal is inserted into a protein and, perhaps more
importantly, to prevent the incorrect metal from binding, cells express metallochaperones38
for some of the tightest binding metals, CuI,39,40 CoII,41,42 and NiII.43 For example, the
greater than femtomolar (10−15 M) affinities of copper enzymes and chaperones for CuI
make the importance of having copper chaperones clear and their identification relatively
facile. Because FeII and MnII are typically the weakest binders to proteins of the biologically
used first row metals,44 however, the existence of chaperones for these metals is less certain.
Some prokaryotes, like E. coli, accumulate μM to mM levels of total iron, much of it in a
“labile iron pool,” weakly bound to proteins or small molecules.45 A major challenge is to
quantify46 and to determine the composition of this pool.47 The deleterious chemistry of the
reactions of FeII with O2 and H2O2 (Fenton chemistry) suggests that sequestering iron in a
less reactive form by a protein chaperone or a small molecule would be beneficial to the cell.
However, whether such proteins or small molecules are involved in transfer of iron to
enzymes through specific interactions is an active area of investigation. Putative iron
chaperones have been reported in eukaryotic systems to transfer of iron into ferritin48 and
prolyl hydroxylases49 (PCBP1 and 2)50 and in iron–sulfur cluster and non-heme diiron
cluster assembly (frataxin51 and Grx 3/447). The dissociation constants of PCBP1 and
frataxin for FeII have been measured to be ~5 μM.48,51 With such weak binding, it is unclear
whether these putative chaperones are essentially glorified small-molecule ligands of a
“labile” iron pool or if they are designed to deliver iron specifically to defined protein
targets. In the case of MnII, studies have also indicated the existence of μM to mM labile
MnII pools52,53 in organisms from lactic acid bacteria to yeast, largely bound to abundant
ligands like phosphate (Kd for MnII binding is 0.5 mM54) and pyrophosphate,53 but no
chaperone proteins have been identified to date. Indeed, perhaps none are necessary as, in
addition to its weak binding to biological ligand sets, the redox chemistry of MnII when
bound to these biological small molecule ligands can counteract oxidative stress (vide
infra),54 in contrast with FeII.37
The weak binding of MnII and FeII to enzymes and metal-sensing transcription factors is
reflected in Table 1. These data highlight two points: first, few Kds are known, and second,
of those that are, the affinities are generally fairly low and in the range of reported cellular
concentrations of the metals (the exception is MnSOD, which will be discussed below).
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Thus correct metallation may be determined by the relative affinities of the two metals for
the protein and the “differential bioavailability” of the two metals in a given growth
condition. This model has been proposed by Culotta and coworkers1 to explain how S.
cerevisiae MnSOD is correctly metallated even in the presence of high, but sequestered,
levels of iron in the mitochondrial matrix. When iron–sulfur cluster assembly is disrupted or
when cells are starved for Mn, however, the protein is mismetallated with Fe.1,55 In a
variation on this theme, correct metallation of a MnII-containing periplasmic protein is
ensured by its folding in the cytosol, where available MnII levels are much higher than those
of Cu and Zn, whereas a related CuII-dependent protein with identical metal ligands folds in
the periplasm, where Cu is more bioavailable.3 As argued above, given the generally weak
binding of MnII and FeII to proteins, protein chaperones would reasonably also bind these
metals weakly and thus not dramatically affect their bioavailable supply any more than a
small molecule would. Thus, whether or not FeII and MnII are sequestered by protein
chaperones in prokaryotes, the model of differential bioavailability may be sufficient to
account for the metallation patterns of the prokaryotic Mn- and Fe-dependent proteins we
now examine, and possibly in general in proteins that do not require more complex cofactors
containing unique ligands, such as nitrogenases7 and hydrogenases.8,9
Interplay of Mn and Fe in biological systems
Replacement of FeII with MnII in non-redox-active enzymes in response to oxidative stress
In a first example of the interchangeability of iron and manganese in aerobes, we focus on
enzymes in which divalent metal ions play roles as Lewis acid catalysts. This issue has
recently been studied by the Imlay lab in ribulose 5-phosphate 3-epimerase, peptide
deformylase, threonine dehydrogenase, and cytosine deaminase. These enzymes were
targeted for study as they show no commonality in mechanism aside from the use of divalent
metal ions as Lewis acid catalysts. Furthermore, the enzymes are active in vitro with
multiple metal ions and the identity of the metal ion(s) used by these enzymes in vivo has
been controversial. Based on genetic and biochemical studies, the Imlay lab has suggested
that these enzymes in E. coli typically use FeII as a cofactor, which is replaced by MnII
under oxidative stress conditions.
Organisms have evolved specialized responses to defend against oxidative stress agents,
such as H2O2 and O2•−.37 These species originate intracellularly from normal aerobic
metabolism as well as extracellularly, such as H2O2 produced by lactic acid bacteria and
streptococci, or O2•− and H2O2 produced by phagosomal NADPH oxidase, in both cases
used as an antimicrobial defense. The amounts of these species that can be tolerated varies
depending on the organism. In E. coli, the H2O2-responsive transcriptional regulator OxyR
is activated at ~0.2 μM intracellular H2O2,69 and levels of 0.5–1 μM have been shown to be
toxic to certain enzymatic pathways, such as iron–sulfur cluster assembly.68,70 During
H2O2-induced stress, OxyR mediates up-regulation of the MnII importer MntH, stimulating
MnII uptake,71 and of the ferritin-like protein Dps, which uses H2O2 to sequester FeII (Fig.
3).72,73 Imlay and coworkers have proposed that this response to decrease bioavailable FeII
and to increase bioavailable MnII (from ~15 to 150 μM)71 represents a strategy to replace
FeII in the active site of some enzymes with MnII. This switch is proposed to protect the
enzymes from self-inactivation by any number of mechanisms that involve FeII oxidation by
H2O2, leading to FeIII dissociation and oxidative damage to the protein.
Recently, ribulose 5-phosphate 3-epimerase (Rpe, Fig. 2), an enzyme in the pentose
phosphate pathway, was identified by Imlay and coworkers as an FeII-utilizing enzyme
under “normal” growth conditions that can self-inactivate under oxidative stress,
accompanied by iron loss.25 Inactivation was prevented by increasing the levels of MnII in
the culture media, presumably by replacing FeII with MnII in the epimerase’s active site.
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Unfortunately, the weak binding of both MnII and FeII to Rpe prevented isolation of
metallated protein and thus the endogenous metal cofactor could not be identified directly.
Instead, the determination relied on activity assays in crude extracts of oxidatively stressed
cells coupled to in vitro assays of recombinant protein metallated with FeII, MnII, CoII, or
ZnII (Rpe copurifies with ZnII when overexpressed in E. coli74).
Further evidence for the proposed metal swap was obtained for three other Lewis acid
enzymes, peptide deformylase, threonine dehydrogenase and cytosine deaminase (CDA).15
As with Rpe, H2O2 inactivates these enzymes in crude extracts, but only the FeII-bound
recombinant enzymes were inactivated in vitro. For the first two enzymes, data suggested
modification of the metal’s Cys ligand, and the inactivation was reversible upon addition of
reductant and FeII. In CDA, in which the metal is not ligated by a Cys, inactivation was only
partially reversible. To test whether MnII was able to prevent inactivation of these enzymes
in vivo, ΔmntH and Δdps mutants were constructed in an E. coli strain that was
constitutively H2O2-stressed. All three enzymes were inactivated, recoverable by addition of
MnII to the culture media except in the case of CDA. Thus the authors suggested that metal
swaps represent a general strategy by E. coli to stave off oxidative damage to enzymes that
typically use iron cofactors. To explain the observation of partial irreversible inactivation of
CDA specifically, it was proposed that Cys ligands to putative FeII cofactors prevent more
serious enzyme damage from reaction of FeII with H2O2. However, cysteine serving as a
ligand to MnII in a biological system would be unprecedented, to our knowledge. In fact,
sulfur (in the form of the thioether of Met) appears to be important for in vivo discrimination
of FeII over MnII by the metalloregulator DtxR from Corynebacterium diphtheriae.75
Unfortunately, direct observation of MnII bound to the proteins has been elusive, due its
weak binding. Also unresolved is whether the putative MnII-bound forms of the proteins are
active in vivo or just protective until the end of oxidative stress, and whether these proteins
are typically MnII enzymes in other organisms for which intracellular manganese is present
in higher concentrations during normal growth (vide infra). Further in-cell methods are
necessary to address these important but difficult questions.
FeII- and MnII-dependent extradiol dioxygenases
Another example of successful metal substitution of FeII and MnII is found in the extradiol
dioxygenases, such as the homoprotocatechuate (HPCA) 2,3-dioxygenases (HPCDs).
Extradiol dioxygenases use a divalent metal site and O2 to cleave the ring of a catecholic
aromatic substrate adjacent to its two hydroxyl groups (Fig. 2B).27 In these enzymes, the
metal ion binds to a 2-His-1-carboxylate facial motif, leaving three open coordination sites,
two of which are occupied by solvent ligands in the resting form of the enzyme.76,77 The
catecholic substrate binds to the metal, occupying two coordination sites, releasing the
bound solvent molecules and leaving one site open for O2 binding (Fig. 1A and 2B).78–80
Most of the extradiol dioxygenases purified to date are assigned as FeII dependent, but a few
are MnII dependent. HPCDs from Arthrobacter globiformis CM-2 (MndD)81 and from
Brevibacillus (formerly Bacillus) brevis,82 and BphC from Bacillus sp. JF883 have been
purified from their native organisms and found to contain MnII. Bacillus sp. JF8 has also
been proposed to encode another MnII-dependent dioxygenase as well as an FeII-dependent
one,84 although the metal selectivities of these proteins have only been examined in
recombinant systems. A dioxygenase from Klebsiella pneumoniae is claimed to be MgII-
dependent.85 While a detailed analysis of the metal requirements of the purified extradiol
dioxygenases is beyond the scope of this review, it is important to note that not all of the
“FeII-dependent” enzymes have been rigorously demonstrated to be iron enzymes in their
physiological growth conditions. For example, although purified from its native organism,
the HPCD from Brevibacterium fuscum86 was purified from growth conditions in which the
minimal medium was supplemented with 50 μM FeII and no other metals.
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To probe the origin of metal specificity and mechanism of the Fe- and Mn-dependent
extradiol dioxygenases, the Lipscomb and Que labs have carried out in-depth metal
substitution experiments with FeII, MnII, and CoII using the B. fuscum (Fe–HPCD) and A.
globiformis (Mn–MndD) enzymes.87 Their results have shown that these two enzymes31
and their “mismetallated” forms all have nearly identical catalytic activities and active site
geometric (Fig. 1A) and electronic structures, despite the disparity in +III/+II reduction
potentials of hexaaquo Co, Mn, and Fe (1.9 V vs. 1.5 V vs. 0.8 V; these values for the
enzyme-bound metals have not been determined).88 These similarities initially led to the
proposal that the mechanism may not involve a metal-based redox reaction.26 Subsequent
mechanistic studies using rapid kinetics methods reported small quantities (5% of total Mn)
of a MnIII-radical intermediate proposed to be MnIII-superoxide89 in the MnII-substituted B.
fuscum HPCD with HPCA as substrate. In a similar set of experiments using an Fe–HPCD
with the active site acid–base catalyst His mutated to Asn, which slows the reaction, and
with 4-nitrocatechol (4-NC), a very slow substrate due to the presence of the electron-
withdrawing nitro group, a FeIII–superoxo intermediate (~10% of total Fe) was
reported.90,91 However, the use of the mutant and unnatural substrate together abolishes ring
cleavage; an important issue is therefore whether this intermediate, although early in the
reaction, is “on-pathway” for the wt enzyme with the natural substrate. Nevertheless, these
results led to a revised model in which the MIII–superoxo intermediate is rapidly reduced by
the catechol substrate to form a reactive MII-(semiquinone)-superoxo species. Thus it is now
proposed that the metal ion serves as a “conduit” for electron transfer between substrate and
O2 and that the metal ion’s redox potential is of little importance for overall enzyme
function as long as the MIII–superoxo can be accessed in a reasonable amount of time.88 In
fact, although a higher metal reduction potential would slow formation of the putative MIII–
superoxo intermediate, it would also favor electron transfer from the substrate to the metal,
perhaps accounting for the similar activities of the CoII-, MnII-, and FeII-substituted
HPCDs.88 How much the protein perturbs the reduction potentials of the bound metal ions
in these systems is at present unknown, but it seems likely that the electron-rich nature of the
substrate is critical for facilitating formation of a MIII–superoxo species with Mn–HPCD to
compensate for the high metal reduction potential. It will be interesting to know if 4-NC can
serve as a substrate for the MnII form of the enzyme, or whether its higher reduction
potentials precludes this reaction. Such studies could help resolve the question of whether
the metal is truly redox active in these enzymes.
Although the interchangeability of metal ions in the active sites of these extradiol
dioxygenases has been established in vitro, the question of whether this interchangeability is
relevant in vivo as well remains unresolved. As we will see below, some of the organisms
that possess putative MnII-dependent dioxygenases (Arthrobacter and Brevibacillus) also
possess class Ib RNRs that are likely Mn-dependent as well. This correlation may suggest
that, while both enzymes could theoretically be metallated with either Mn or Fe in vivo, the
overall MnII versus FeII concentrations in these organisms are the primary determinants of
“metal selectivity” in these enzymes and are responsible for the observed metal
dependences.
Fe– and Mn–SODs
In the case where the Fe and Mn ions must undergo changes in redox state during catalysis,
the consequences of mismetallation change. The classic example is the Fe– and Mn–SODs,
which disproportionate superoxide to O2 and H2O2, cycling between their+ II and+ III states
(Fig. 2C). These enzymes are structurally homologous, and their active sites are identical in
the first coordination sphere (Fig. 1B). While there have been a few reports of “cambialistic”
SODs that are active with either metal,92 most Mn– and Fe–SODs, like those of E. coli,
display significant activity only with one metal. As recently summarized by Miller,28 each
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Mn– or Fe–SOD tunes the redox potentials of its “correct” metal ion to fall between the
potentials of the two half-reactions (0.89 V for O2•− reduction to H2O2, −0.16 V for
reduction of O2 to O2•−).93 Because of the higher reduction potential of MnIII than FeIII, the
Mn–SOD protein must depress the reduction potentials of its bound metal much more than
Fe–SOD; therefore substitution of Fe in a Mn–SOD would generate a protein only able to
reduce O2•−.94 SODs modulate the potentials of their respective metal ions by differential
tuning of hydrogen-bonding interactions between solvent ligands to the metals and the
protein scaffold.28,94,95 As with the extradiol dioxygenases, there is no marked preference
for Fe over Mn binding or vice versa. For example, given that the cellular MnII and FeII
concentrations are much higher than the Kds for E. coli MnSOD given in Table 1 and that
metal binding has been shown to be irreversible,2 the enzyme’s affinities for MnII and FeII
are similar enough that MnSOD is metallated with both Mn and Fe in wildtype E. coli
grown in rich medium.21 While this may seem inefficient, E. coli also encodes an Fe-
dependent SOD; furthermore, in oxidative stress and Fe deficiency, MnSOD is induced and
becomes preferentially loaded with Mn,96,97 probably as a result of both lower levels of free
iron (through its oxidation to FeIII) and higher levels of MnII due to increased Mn import
(Fig. 3).
The complexity of metallation of SODs with Fe and Mn is also illustrated by recent studies
of the enzymes from the pathogen Bacillus anthracis.22 Waldron and coworkers grew B.
anthracis in rich media, lysed cells anaerobically, separated the lysate by two-dimensional
liquid chromatography, and analyzed Fe and Mn contents in the resulting chromatography
fractions. While a limitation of this method is that only proteins that tightly bind their metal
cofactors can be identified, SODs fall into this category. The researchers found that B.
anthracis contains one SOD primarily loaded with Mn (SodA1, with 13% containing Fe) and
another (SodA2) exclusively loaded with Fe. The two SODs were also cloned and
overexpressed in E. coli, both copurifying mostly with Fe. Whereas Fe could be removed
from SodA1 and the protein could be reconstituted with MnII to increase activity 30-fold,
SodA2 could only be loaded and activated with Fe, unusual as most apo-SODs can be
mismetallated in vitro by the same protocol as they are metallated. The observation that
SodA1 is primarily loaded with Mn in B. anthracis even in rich media and loaded primarily
with Fe when overexpressed in E. coli suggests that Mn and Fe pools are not as imbalanced
in B. anthracis as they are in E. coli, or that metallation of SodA1 with Mn in B. anthracis
requires a MnII chaperone.
In support of the former option, typical MnII levels are likely higher in B. anthracis than in
E. coli (15 μM in normal growth conditions) based on the affinity of the MnII-dependent
transcriptional regulator AntR for MnII.63 Metalloregulatory proteins translate information
about intracellular metal concentrations into a transcriptional response through differences
in affinity for their DNA binding sites in the apo and metal-bound forms; therefore, their
Kds for their cognate metals should approximate the typical intracellular “free”
concentrations of those metals.98 For example, the concentrations of “free” Cu and Zn ions
in the cell are vanishingly low,45,99 and the sensors for these ions in E. coli have Kds in the
10−15–10−21 M range.100,101 AntR binds two MnII per monomer in a positively cooperative
process with Kds of 210 and 17 μM,63 suggesting “free” MnII levels in the 100–200 μM
range in B. anthracis. Thus, while metallation of SodA1 may be driven by high Mn levels,
SodA2 may need to exclude MnII binding, as it does in vitro, by a yet to be determined
mechanism in order to be metallated with Fe in vivo.
Interestingly, unlike E. coli,71 oxidative stress does not appear to induce MnII import in
wild-type B. anthracis;22,102 however, growth of B. anthracis is impaired in sodA1 and
sodA2 mutants cultured in Mn-depleted media.102 These results, together with the affinity of
AntR for MnII, may suggest that pools of MnII are important in normal growth for this
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organism and are essential in the absence of enzymes for oxidative defense. Such a
cytoprotective function for MnII pools is reminiscent of the observation that some bacteria
have done away with SOD enzymes altogether, instead relying on non-enzymatic
disproportionation of O2•− by cellular MnII. The utility of “free” Mn for oxidative defense
has been supported by in vitro54,103 and in vivo53 evidence. MnII–phosphate complexes, for
example, can catalyze disproportionation of O2•− at a rate sufficient to manage O2•− stress at
biologically accessible concentrations of MnII and phosphate. This chemistry has also been
proposed to be exploited by pathogens, for which manganese transporters have been shown
in a number of cases to be key for virulence.104,105 These data indicating MnII accumulation
suggest that the strategy of utilizing MnII to help combat oxidative stress is widely
conserved; even organisms like E. coli, for which MnII plays an apparently minor role in
growth in iron-rich media, revert to this strategy in conditions of oxidative stress, as
illustrated by the example of Rpe described above.25,71
Class I ribonucleotide reductases
The most complex substitution of Mn and Fe observed so far is found in the class I RNRs.
RNRs catalyze the reduction of nucleoside 5′-di- or triphosphates (NDPs or NTPs) and
constitute the only pathway for de novo synthesis of deoxy-nucleotides in all
organisms.106,107 Nucleotide reduction is initiated by abstraction of the 3′ hydrogen atom of
the NDP substrate by a thiyl radical108 generated transiently in the active site. After loss of
the substrate 2′-OH as water and reduction concomitant with oxidation of cysteine residues
to a disulfide, the 3′ hydrogen atom is returned to C3′, regenerating the thiyl radical (Fig.
2D).109 Nature has devised three ways of reversible formation of the thiyl radical (Fig. 4). In
the class III RNRs, expressed only under strictly anaerobic conditions, the cysteine is
oxidized directly by a stable glycyl radical in turn generated by a radical-S-
adenosylmethionine activating enzyme.110 In the O2-independent class II RNRs, a 5′-
deoxy-adenosyl radical formed by homolysis of the cobalt–carbon bond of
adenosylcobalamin oxidizes the cysteine.110 In the O2-dependent class I RNRs, the active
site cysteine in the α2 subunit is oxidized by a metallocofactor 35 Å away in the β2 subunit
of the enzyme by a proton-coupled electron transfer pathway composed of conserved
aromatic amino acid residues.111–113 The β2 subunit is homologous to other, mostly diiron
proteins of the ferritin superfamily such as methane monooxygenase, Δ-9 desaturase, Dps,
ferritin, and the Mn-dependent catalases.114–116 As a result of several recent discoveries, the
class I RNRs have been divided into three subclasses – Ia, Ib, and Ic – based on identity of
the metallocofactor (Fig. 4).30 Phylogeny, details of allosteric regulation, and requirements
for unique accessory factors for metallocofactor assembly also help to distinguish these
subclasses.
Just five years ago, the role of a manganese-containing metallocofactor in any class I RNR
was controversial; the class Ia, Ib,107,117 and Ic118,119 enzymes were all generally believed
to be di-iron proteins in vivo. The class Ia RNRs are found in all eukaryotes and some
prokaryotes, such as E. coli.120 The E. coli class Ia RNR was the first to be purified and is
the best characterized system to date. Classic experiments in the 1970s identified the source
of an EPR signal in preparations of the β2 subunit (NrdB) as a tyrosyl radical (Y•),121–123
which was subsequently localized to a tyrosine residue adjacent to a μ-oxo-bridged diferric
cluster (Fig. 1C).124 This Y• was the first protein radical observed in biology. The Y• is
absolutely essential for RNR activity and activity scales with Y• content.125 In vitro
experiments carried out by Atkin et al.126 demonstrated that the diferric-Y• cofactor could
self-assemble from apo-NrdB, FeII, and O2. Numerous studies using an arsenal of
biophysical methods support the general mechanism of diferric-Y• cofactor assembly shown
in Fig. 5A.127–131 The “extra” electron required can be derived in vitro from FeII, ascorbate,
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or thiols,127 but in vivo in E. coli, it is proposed that the [2Fe2S]-ferredoxin YfaE is the
source of this reducing equivalent (vide infra).132
The class Ib RNRs – found only in prokaryotes, including numerous pathogens such as
Mycobacterium tuberculosis, B. anthracis, and Staphylococcus aureus, in addition to E. coli
– exhibit low sequence identity with class Ia RNRs (~30% for E. coli class Ia and Ib RNRs).
Nevertheless, the class Ib RNR α2 (NrdE)133 and β2 (NrdF)134 subunits are structurally
homologous to the corresponding class Ia subunits and possess identical metal-binding
residues (Fig. 1C). The second coordination spheres are subtly different (discussed in detail
in ref. 35 and 134). Evidence primarily from the Auling and Follmann laboratories in the
1980s and 1990s suggested that corynebacterial NrdFs bind Mn inside the cell.135,136
However, definitive identification of the cofactor was hampered by the inherent instability
of Y• and consequent very low specific activity due to the extensive period required for
purification. No Y• was detected and hence its relationship to Mn content could not be
correlated. At the same time, the diferric-Y• cofactor had been shown by a number of groups
to self-assemble from apo-NrdF, FeII, and O2, just as in class Ia RNRs, and was catalytically
active. By contrast, Y• could not be detected in efforts to self-assemble the cluster from MnII
with O2.117 Therefore, the diferric-Y• was assumed by some117,137 to be the actual cofactor
of the class Ib RNRs in vivo.
Recently, however, studies from our lab12 and the Auling and Lubitz labs13 demonstrated
definitively that a MnIII 2-Y• cofactor could be generated in vitro and in vivo, respectively.
In the former case, this process was shown to require12,138 the presence of a conserved
accessory protein, NrdI139,140 (Fig. 5B). The physiological relevance of the dimanganese
cofactor has recently been demonstrated under a variety of growth conditions in
Corynebacterium ammoniagenes,13 E. coli,66,141 and B. subtilis.142 The observation that
both MnIII 2-Y• and FeIII 2-Y• cofactors in the class Ib RNRs can initiate nucleotide
reduction in vitro, however, raises the issue as to whether certain growth conditions will
favor the formation of the latter cofactor in vivo as well.
The class Ic RNRs (Fig. 5C), identified by sequence analysis in a limited number (~50 as of
2010)143 of prokaryotes, have replaced the conserved tyrosine residue adjacent to the metal
cluster of the class Ia and Ib RNRs with a non-oxidizable residue such as Phe.118 Therefore,
the oxidizing equivalent necessary for thiyl radical formation must be stored in the metal
cluster itself. Early experiments118,119 on the Chlamydia trachomatis RNR, the only class Ic
RNR studied to date, suggested that a FeIIIFeIV cofactor, the analogue to the tyrosine-
oxidizing intermediate of the class Ia RNRs (X, Fig. 5A), was active in nucleotide reduction.
However, subsequent work of the Bollinger–Krebs lab23,144 established that the protein
could be activated with an unprecedented MnIVFeIII cofactor by the general mechanism
shown in Fig. 5C and suggested that the FeIIIFeIV cofactor is inactive. The history of the
discovery of the C. trachomatis class Ic RNR’s MnIVFeIII cofactor has been recently
reviewed29,30,145,146 and will not be described in detail here. Important unresolved issues
remain, however, including whether the FeIIIFeIV form is totally inactive23 or can catalyze a
single turnover147,148 and the identity of the physiological cofactor. Because the in vivo
metallation state of class Ic RNRs has not been established and because the class Ib RNRs
are the only RNRs that can catalyze multiple turnovers using two different cofactors, we
primarily restrict our remaining discussion to the class Ib RNR.
Determination of a physiological metallocofactor: the class Ib RNRs
In 1988 Auling and Follman isolated a manganese-containing RNR from C. ammoniagenes
that had very low enzymatic activity and no detectable Y•.136 Based on their results and the
biology of C. ammoniagenes,135,149,150 they proposed that there would be a manganese,
tyrosyl radical-dependent RNR. However, a controversy over the identity of the class Ib
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RNR metallocofactor has persisted until recently, due to inability to detect the proposed Y•.
The history has been recently recounted29,30,151 with the important milestones summarized
in Table 2. Briefly, the incorporation of active diferric-Y• cofactor into NrdFs during their
overexpression in E. coli in rich media,152 the ability to self-assemble an active diferric-Y•
cofactor in vitro as in the class Ia RNRs,117 the inability to self-assemble an active
manganese-Y• cofactor under a range of conditions,12,117 and the low activity associated
with the purified manganese-containing RNRs,136,153,154 led several groups to favor the
importance of the iron cofactor in vivo and to propose that the activity of the manganese-
containing RNR was associated with small amounts of active diferric-Y• cofactor. However,
in late 2009, Auling and coworkers published evidence strongly suggesting that NrdF from
Corynebacterium glutamicum, closely related to the C. ammoniagenes NrdF, contained a
manganese-Y• cofactor.155
The role of NrdI
The definitive link between the presence of manganese in NrdF, Y•, and nucleotide
reduction activity was provided when we demonstrated for the first time that an active
MnIII 2-Y• cofactor could be assembled in vitro.12 The key was the consideration that a
biosynthetic pathway would be essential for formation of the metallocofactor, and the
missing link was provided by NrdI. In 2008 we had shown that nrdI, a universally conserved
gene in organisms containing class Ib RNRs and often located on an operon with nrdE and
nrdF,120 encodes a flavodoxin-like protein that interacts with NrdF.140 When apo-NrdF was
incubated with MnII and reduced NrdI (NrdIhq) and then exposed to O2, Y• coupled to a
dimanganese cluster, proposed to be MnIII 2 based on UV-vis and EPR evidence and
mechanistic considerations, was generated.12 Further experiments suggested that NrdIhq
bound to NrdF and, when reacted with O2, produced an oxidant that was channeled to the
metal cluster in NrdF. This proposal was supported by crystallization of E. coli NrdI·MnII 2–
NrdF complexes,138 which revealed a channel connecting the FMN cofactor in NrdI to Mn2
in the MnII 2 site in NrdF (Fig. 6). The hydrophilicity of the channel and the nearly
completely conserved residues from NrdF and NrdI that line the channel support a
hydrophilic oxidant such as HOO(H) or O2•−;30 the identity of the oxidant is unresolved.
Based on structure and sequence alignments, this channel is located in the same area as the
previously proposed access route for O2 to the diferrous site of the class Ia RNRs.156,157
Interestingly, NrdIhq is unable to activate the class Ia RNR loaded with MnII 2 cluster,
despite the structural similarity of the class Ia and Ib diferrous and dimanganese(II)
sites.35,141,158 Thus the key to MnIII 2-Y• cofactor assembly in the class Ib, but not class Ia,
RNR is that MnII 2–NrdF forms a complex with NrdI and a unique channel for oxidant
delivery.
Contemporaneous with our studies on the E. coli system, C. ammoniagenes NrdF containing
a MnIII 2-Y• cofactor was finally isolated from its endogenous host in sufficient quantities
for its metallocofactor to be characterized.13,159 Detailed EPR analysis and a high-resolution
crystal structure, combined with the results from the E. coli in vitro assembly system,
supported the presence of a MnIII 2-Y• cofactor in both C. ammoniagenes and E. coli NrdFs.
Shortly thereafter, E. coli NrdF was isolated from E. coli grown under Fe-limited141 and
oxidative stress66 conditions, and B. subtilis NrdF was purified from its native organism.142
Both were shown to contain MnIII 2-Y• cofactors. Thus the physiological relevance of the
MnIII 2-Y• cofactor is now clear, consistent with the early studies indicating dependence on
Mn for corynebacterial growth.
Cofactor self-assembly: are additional factors needed?
Subsequently, in vitro assembly of MnIII 2-Y• cofactor in NrdF from MnII, O2, and NrdIhq
and of diferric-Y• cofactor from FeII and O2 has been demonstrated for B. subtilis,142 B.
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anthracis160 and B. cereus.161 The ability to form active, dimanganese and di-iron cofactors
is likely a general feature of the class Ib RNRs and may have interesting biological
implications. In all cases reported thus far, the activity of the MnIII 2-Y• NrdF is 5–10 times
higher than that of FeIII 2-Y• NrdF. However, in in vitro studies to date, only 0.25–0.6 Y•/β2
are generated and 1.4–1.8 Mn/β2 are oxidized, far less than the theoretical maximum of 2
Y•/β2 and 4 Mn/β2. It is possible that the sub-optimal MnIII 2-Y• cofactor assembly results
from use of NrdI stoichiometrically for in vitro cluster assembly rather than catalytically, as
it is used inside the cell141,142 with a yet to be identified reductase. Alternatively, optimal
metal loading may require additional protein factors. By contrast, diferric-Y• assembly has
been optimized over many decades of study at ~1 Y•/β2 and ~3.5 Fe/β2 in class Ia RNRs.
As with MnIII 2-Y• NrdF, more metal is oxidized during cluster assembly than is associated
with Y•. Furthermore, whether 1 or 2 Y•/β2 represents the cofactor loading in vivo is still
unclear; inherent instability of the Y• makes it impossible to address this question directly by
purification of β2 subunits from endogenous levels. Clearly, unresolved issues remain even
after four decades of study of the assembly of the diferric-Y• cofactor.
Recent work has hinted at a possible solution to these issues. In the case of the class Ib
RNR, the presence of nrdI in an operon with nrdEF ultimately led to its identification as an
essential accessory factor in MnIII 2-Y• cofactor assembly. Similarly, the E. coli class Ia
RNR nrdAB genes are present in an operon with a gene, yfaE, which is co-transcribed with
nrdB162 and was predicted to encode a putative ferredoxin. Studies from our lab have
recently shown that YfaE is a [2Fe2S]-ferredoxin-like protein that can, in fact, transfer
electrons to NrdB,132 suggesting that the protein could be involved in provision of the extra
electron required in cofactor assembly (Fig. 5A). In support of this hypothesis, cluster
assembly in vitro with reduced YfaE in excess led to 1.5 Y•/β2, and the stoichiometry of
assembly suggested the extra reducing equivalent for assembly derived from YfaE.132
Furthermore, when cells overexpressing NrdB that was fully iron loaded were titrated with
reduced YfaE, ~2 Y•/β2 were formed, the highest levels of Y• ever observed.163 By contrast,
FeII, ascorbate, and thiols act as kinetically efficient electron donors to NrdB during in vitro
diferric-Y• assembly and yet lead only to ~1 Y•/β2. Therefore, while supporting YfaE’s role
in electron delivery, these experiments also suggest that YfaE has an additional function in
cluster assembly, as reinforced by genetic experiments discussed below. These results from
class Ia and Ib systems highlight a general caveat: even when a metallocofactor can self-
assemble in vitro, there may be other protein factors involved in cofactor formation in vivo
that must be identified. In the absence of these factors in vitro, self-assembly may be sub-
optimal.
Control of metallation of class I RNRs
The fact that two different cofactors generated from different oxidants and requirements for
reductant can be assembled from the same active site raises the issue of whether both, or
only one, can be used in the wide range of environments an organism encounters. In the
remainder of this review, we consider the implications of these observations for the
physiological relevance of these two cofactors in the class Ib RNRs.
As noted above, how the class I RNRs successfully discriminate between FeII and MnII in
vivo may be a consequence of relative affinities and metal availability. Unfortunately, metal
availabilities are difficult to determine experimentally, as laboratory growth conditions
rarely mimic physiological conditions and the speciation of “bioavailable” metals inside the
cell is largely unknown. For pathogens, the situation is even more complex, as the host
organism influences metal homeostasis for the pathogen,104 making selection of an
appropriate macrophage or animal model key to extraction of physiologically relevant
information. However, unlike the enzymes discussed earlier in this review, class I RNRs
have an additional filter for selectivity between FeII and MnII: the use of accessory factors
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involved in conversion of the reduced, inactive form of the protein to the oxidized, active
form. Work with class Ib RNRs described above has made it clear that NrdI plays an
essential role in MnIII 2-Y• cofactor assembly via electron donation to O2 to produce the
active oxidant. Studies of YfaE suggest the involvement of accessory factors in class Ia
RNR cluster assembly in vivo as well. While there remain many issues to resolve, we
suggest that aerobic prokaryotes have evolved three general strategies to ensure correct
metallation of their class I RNRs depending on their general metal homeostatic machinery
and RNR expression patterns. First, organisms containing both class Ia and Ib RNRs control
RNR expression such that the class Ib is only expressed in Fe-limited or oxidative stress
conditions. Second, organisms containing only class Ib RNRs tend to accumulate high levels
of MnII, which may dictate the cofactor used by the RNR. Third, organisms containing class
Ic RNRs, which are not present in the same organisms as class Ia or Ib RNRs, likely have
more complex considerations if the MnIIIFeIV cofactor is physiologically relevant.
Organisms containing both class Ia and Ib RNRs
Facultative aerobes that express both class Ia and Ib RNRs are almost exclusively
enterobacteriaceae, like E. coli and Salmonella enterica serovar Typhimurium (S.
Typhimurium). Under normal laboratory growth conditions, the levels of intracellular Mn in
E. coli have been measured to be ~15 μM,45,71 whereas iron levels are ~0.1–1 mM.45,164 To
consider whether differential bioavailability is a plausible model for RNR metallation in
these systems without need to invoke specific FeII delivery factors, the Kds of apo-NrdB for
FeII and MnII and kinetics of metal binding and reaction with oxidant have to be considered.
Unfortunately, this information is incomplete. The Hendrich lab has reported Kds for MnII
binding to E. coli apo-NrdB of 2 and 26 μM (Table 1), assigned to metal sites 2 and 1 (Fig.
1C), respectively.58 Both Kds are in the range of typical Mn concentrations in the cell in
defined medium.71 The affinity of the protein for FeII is unknown, but, based on the
qualitative observation that MnII inhibits diferric-Y• assembly,158 it is probably lower than
for MnII. Without knowledge of the Kds for FeII binding and of metal speciation in the cell,
the state of class Ia RNR metallation under the physiological conditions of~0.1–1 mM
iron45,164 and~2 μMβ2 cannot be predicted.163 It is possible that FeII binding could
outcompete MnII without requiring a chaperone. In support of the idea that FeII can be
readily pulled from the labile iron pool and cluster assembled, up to ~120 μM β2 is
completely loaded with iron in rich media when NrdB is expressed from a titrable,
arabinose-inducible promoter.163 Furthermore, the reactivity of the FeII 2 cluster with O2
relative to MnII 2 and mixed MnIIFeII clusters158,165 could allow sufficient time for
inappropriately loaded metals to dissociate and re-metallate correctly. Our recent results
suggest that even when E. coli are grown under severe Fe limitation with MnII
supplementation, conditions under which NrdF is expressed and active,141 NrdB is also
expressed. However, its activity is very low, likely due to MnII loading. When FeII levels are
increased in the growth media, mismetallation of NrdB may be reversible.
The correct metallation of the E. coli class Ia RNR may also be aided by the accessory
factor, YfaE (Fig. 7). In addition to the biochemical data presented above pointing to an
important role for YfaE in diferric-Y• cluster assembly, Martin and Imlay66 have recently
found that yfaE is essential for NrdB’s discrimination between FeII and MnII during
oxidative stress conditions (0.5–1 μM H2O2), but not under iron limitation or normal growth
conditions. As with the biochemical data, a simple role in provision of the extra electron
required in cofactor assembly (Fig. 5A) does not seem sufficient to explain this observation.
One possibility is that YfaE could act as an iron chaperone to NrdB, as has been discussed
elsewhere.30,166 A second possibility is that YfaE binding to NrdB could influence the
kinetics of FeII and/or O2 access; the rate-limiting step in formation of the tyrosine oxidizing
intermediate X (Fig. 5A) in class Ia RNR cofactor assembly in vitro is a conformational
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change associated with FeII binding.167–169 Further studies are required, however, to
understand YfaE’s role in E. coli NrdB assembly. Intriguingly, YfaE is not essential is most
growth conditions, nor is it universally conserved in organisms containing class Ia RNRs
(unlike NrdI for class Ib RNRs). This suggests that other organisms have evolved distinct,
though possibly related, strategies to optimize class Ia cluster assembly in vivo.
In contrast to the class Ia RNR, under “normal” intracellular iron levels in E. coli, the class
Ib RNR is not significantly expressed.170,171 Early studies171–173 showed that iron limitation
and oxidative stress lead to upregulation of the class Ib operon (nrdHIEF; nrdH encodes a
reductant for NrdE). Our purification of active NrdF from an iron-limited E. coli strain141
and genetic and whole-cell EPR studies of Martin and Imlay66 of E. coli experiencing
oxidative stress71 have together shown that the class Ib RNR is expressed, is active, and
contains a MnIII 2-Y• cofactor under these conditions. The mechanisms by which this occurs
in both cases are linked, as shown in Fig. 3.
Iron limitation is sensed in E. coli by the FeII-responsive transcriptional regulator Fur,
usually by binding of FeII–Fur to a sequence upstream of the promoter region to repress
transcription of a wide range of genes involved in iron homeostasis. FeII–Fur also positively
regulates certain genes, such as Fe–SOD, a process that is mediated posttranscriptionally by
the small RNA RyhB, which is itself negatively regulated by FeII–Fur.174 In low FeII
conditions, when Fur is largely in the apo form, Fur’s affinity for its binding site decreases,
and genes in its regulon, such as the nrdHIEF operon66,175,176 and mntH,65,177 are
transcribed. MntH expression subsequently leads to MnII import, ultimately facilitating
loading of NrdF with MnII.
Oxidative stress also favors MnIII 2-Y• cofactor formation in NrdF. One of the sensors of
oxidative stress in E. coli is the transcriptional regulator OxyR. H2O2 stresses of >0.1–0.2
μM lead to oxidation of two Cys residues to a disulfide bond on OxyR,67 activating
transcription of various genes involved in oxidative stress response, including dps and mntH
(Fig. 3). As described above, Imlay and coworkers have proposed that H2O2 also leads to
oxidation of the mononuclear FeII cofactors of many enzymes such as Rpe to FeIII, which
dissociates, inactivating the enzymes.15,25 H2O2 also inactivates FeII–Fur in vivo, plausibly
by a similar mechanism of oxidation of Fur-bound FeII (although no biochemical studies of
this have been reported), thus mimicking iron limitation and leading to derepression of Fur-
regulated genes.64 To combat these effects, iron is sequestered by the ferritin-like protein
Dps to limit the Fenton chemistry associated with iron and H2O2, and MnII import may
serve to protect the normally FeII-enzymes from oxidative damage. Recent work has also
indicated that nrdHIEF is regulated by apo-IscR.66 IscR contains a [2Fe2S] cluster in its
holo form and negatively regulates the “housekeeping” iron sulfur cluster biosynthesis
pathway, Isc.178 Oxidative stress disrupts this pathway, possibly initially by destruction of
the [2Fe2S] cluster on IscR, leaving the apo form,68 although again no biochemical studies
of the effect of H2O2 on [2Fe2S]-IscR have been reported. Apo-IscR can act as a positive
regulator of other genes, such as the backup Suf iron–sulfur cluster assembly system and
nrdHIEF.179 Therefore, under oxidative stress or Fe limitation, multiple pathways converge
to create conditions favoring metallation of NrdF with MnII.
These results suggest that NrdF is only expressed when it can be correctly metallated with
Mn. Therefore, correct metallation of E. coli NrdB and NrdF may be ensured by controlling
the expression patterns of these proteins in response to metal availability. We suggest this
will be true for other organisms that contain both class Ia and Ib RNRs as well. This
hypothesis is supported by studies of class Ia and Ib RNR mutants of the related pathogen S.
Typhimurium during infection of macrophages. Gibert and coworkers176 found that NrdEF,
but not the class Ia NrdAB, plays a key role in early stages of infection (up to 6 h).
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However, a S. Typhimurium ΔnrdAB mutant is inviable at 24 h (once the pathogen’s
virulence response has been induced180) unless the macrophage is lacking Nramp1, the
divalent metal transporter responsible for efflux of metals from the phagosome, and the cells
are exposed to an iron chelator. Although these experiments were conducted before the
physiological relevance of the Mn cofactor of NrdF in E. coli was reported, one
interpretation is that NrdEF can sustain growth only as long as Fe levels are low, either
because NrdF is not expressed at high enough levels in Fe-sufficient conditions,171,181 or
because the activity of FeIII 2-Y• NrdF, if it can form in vivo, is too low.12,66 These data
suggest that NrdF is activated only by manganese in vivo in these organisms.
Organisms containing only class Ib RNRs
Unlike E. coli, many of the numerous prokaryotes that encode class Ib RNRs as their sole
class I RNRs contain high concentrations of manganese even under normal growth
conditions, and we suggest that this may drive Mn loading of their class Ib RNRs.
Lactobacillus plantarum,52 Deinococcus radiodurans,182,183 B. subtilis,62 and
Staphylococcus aureus,184 accumulate 20 mM, ~200 μM, ~100 μM, and >50 μM MnII,
respectively, under “normal” laboratory growth conditions.185 In these organisms, the
presence of high levels of MnII would likely readily outcompete FeII loading of a class Ia
RNR, which may be reflected in the utilization of a class Ib RNR. In fact, C. ammoniagenes
restricts incorporation of Fe into NrdF when the protein is overexpressed in its native
organism in medium containing 185 μM Fe with no added Mn.13,159 The B. subtilis class Ib
RNR also contains a MnIII 2-Y• cofactor even when grown in rich medium, albeit when it is
overexpressed 35-fold.142
It is also possible that metallation of certain class Ib RNRs may be analogous to non-redox
Fe/Mn enzymes in that NrdF could be loaded and active with both dimanganese and diiron
cofactors in different growth conditions in the same organism. One would expect this
situation to be most likely in organisms whose NrdFs are comparably active with MnIII 2-Y•
and FeIII 2-Y• cofactors. The first such organism is Streptococcus sanguinis.186 Although
available intracellular Fe and Mn concentration data for this and other streptococci are not
easily translatable to concentrations (μM) for comparison with the metal concentrations
mentioned above, the related S. pneumoniae has been reported to accumulate similar levels
of Mn and Fe (300 ng mg−1 protein),187 suggesting the plausibility of metal loading and
assembly of both Mn and Fe cofactors in vivo. Other studies of S. pneumoniae have reported
somewhat higher Fe concentrations (900 ng mg−1 protein).164 However, the speciation of
these metals (i.e., whether the two metals are equally “bioavailable”) is unknown. If both
metals are similarly bioavailable in certain conditions, the organism may tolerate loading of
a fraction of its class Ib RNR with iron, as occurs with partial mismetallation of MnSOD
with Fe even when the Fe-loaded MnSOD is inactive.21,22
The dependence on NrdI for MnIII 2-Y• cofactor assembly provides a unique handle by
which the question of metal loading of NrdF in vivo can be assessed without requiring
purification of active NrdF from many growth conditions. Our favored interpretation of the
universal conservation of nrdI is that the MnIII 2-Y• cofactor is relevant in all organisms in at
least some set(s) of growth conditions. However, because NrdI can also transfer electrons to
FeIII 2-NrdF in vitro,140 it is also possible that NrdI acts as the extra electron source for
FeIII 2-Y• cofactor assembly in some organisms under certain growth conditions (Fig. 7). As
the FeIII 2-Y• cofactor can self-assemble in vitro from FeII and O2 alone, it is expected that
assembly of this cluster could still proceed in vivo in the absence of NrdI using cellular
thiols, ascorbate, or generic flavodoxins or ferredoxins188 as a donor of the “extra” electron
in the assembly process. In contrast, deletion of nrdI would be expected to be lethal for
organisms whose NrdF uses Mn only.
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Only three studies of the essentiality of NrdI have been carried out to date. Gene inactivation
studies have indicated that nrdI, for example, is essential for growth of B. subtilis189 and S.
sanguinis190 in rich media. More detailed studies have been recently reported by Sjöberg
and coworkers on the nrdI genes of Streptococcus pyogenes, which utilizes only class Ib
RNR genes for aerobic growth.139 Their reported experiments are complicated by two
factors. First, S. pyogenes contains two sets of class Ib RNR genes, only one of which is
active in vitro. Second, a heterologous complementation assay in rich media in an E. coli
strain unable to reduce nucleotides aerobically was used to assess the activity of the S.
pyogenes genes in vivo. While they concluded from their studies that one of the nrdI genes,
denoted nrdI*, is essential, the experimental results are sufficiently complex to remain
inconclusive. However, use of standard genetic and biological methods including deletion
strain construction, homologous complementation assays, and in vivo assays of virulence for
the many pathogens that depend on class Ib RNRs should enable assessment of the
essentiality of NrdI in physiological growth conditions in many organisms. We anticipate
that it will be found to be, suggesting that class Ib RNRs are manganese enzymes in general.
Metallation of class Ic RNRs
Metallation of the C. trachomatis class Ic RNR must be more complex than for class Ia and
Ib RNRs because of its heterodinuclear cofactor and the reactivity of the FeII 2 form with O2
to generate a likely inactive FeIIIFeIV cofactor. In vitro reconstitution studies from apo-
NrdB23,144,191 or overexpression of NrdB192,193 in E. coli grown in rich medium
supplemented with MnII have demonstrated challenges associated with loading two metals.
Both studies have resulted in crystallographic characterization of NrdB with distinct results.
In the NrdB reconstituted with Mn and Fe in vitro, Mn appears to be present at both sites 1
and 2 (although mainly at site 1),191 whereas in the NrdB expressed recombinantly in the
presence of added MnII, Mn appears to be localized to site 1.193 However, the former results
indicate that the method of reconstitution impacts the metal distribution in the oxidized
protein, whereas the interpretation of the latter results is complicated by the presence of
MnII and PbII in the crystallization conditions. C. trachomatis is an obligate intracellular
parasite and isolation of its RNR from its endogenous environment in sufficient amounts to
characterize the cofactor biosynthesized in vivo likely presents an insurmountable challenge.
Thus identification of a class Ic RNR from a more tractable organism whose physiological
niche is understood may allow biochemical and biological studies of this fascinating
metallation problem.
Synthesis and conclusions
The examples presented in this brief review illustrate the diversity of Fe/Mn interchange
reactions in biology. In each case, the specific role of the metal ion in catalysis dictates the
specific strategy used for the switch. For non-redox Lewis acid enzymes that use FeII or
MnII as a cofactor, the metal can be simply exchanged. For dioxygenases, if in fact they are
redox active, use of an electron-rich substrate may allow MnII to be used in place of FeII.
For SODs, a similar but distinct active site is necessary to perturb the redox potentials to
bring them in the range for catalyzing both reduction and oxidation of O2•−. For RNRs, a
different oxidant is used to overcome the inability of O2 to oxidize MnII; the same protein
can be used, but only if the unique accessory protein NrdI is present to produce that oxidant.
Beyond demonstrating Nature’s remarkable chemical creativity, we have discussed these
systems together to illustrate that, in the absence of functional reasons to use one specific
metal ion over another, an organism’s utilization of Mn over Fe or vice versa for a particular
enzyme is likely a response to environmental factors that will also be reflected in the
metallation of other enzymes that can use either Mn or Fe. In this view, in E. coli,
replacement of FeII with MnII in Rpe in oxidative stress conditions,25 upregulation of
MnSOD in Fe limitation,97 and expression of the Mn-dependent class Ib RNR in the same
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conditions66,141 are not isolated phenomena but reflections of a shift to a more Mn
dependent metabolism in these conditions (Fig. 3). Many of the Fe-dependent extradiol
dioxygenases purified to date are from pseudomonads, which contain Fe-dependent class Ia
RNRs. However, the few dioxygenases likely to be Mn-dependent in vivo are from
organisms like Arthrobacter, whose class Ib RNR is also likely to beMn-dependent,194 or
Brevibacillus brevis, whose class Ib RNR is closely related to that of B. subtilis and
therefore may also be manganese dependent. These observations may not be coincidental.
We suggest that the metal usage of these diverse protein systems is linked, reflecting the
overall metal usage by the organism. Further work is necessary to determine if these
proposed connections are valid and generalizable.
A number of issues have to be considered to propose a global model for how Nature
manages metal homeostasis to minimize mismetallation, despite the use of protein scaffolds
that exhibit little inherent metal ion specificity. Ultimately, the answers to this question will
require more complete information: total and bioavailable metal concentrations in a variety
of organisms in different growth conditions, Kds of the distinct metal ions for their
respective proteins, cellular concentrations of these proteins, protein expression patterns,
kinetics of cofactor assembly, speciation of “free” metal ions in cells, and whether metal
chaperones for weakly binding metals like MnII and FeII exist in general. This is an
ambitious undertaking but, as more organisms and protein systems are studied and new
metallomic methods3,22,195,196 are applied, the issues of the cellular interplay between
manganese and iron specifically and of mismetallation in general will come into focus.
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Fig. 1.
Comparison of the metal binding sites of Fe- and Mn-containing extradiol dioxygenases (A),
SODs (B), and the class Ia and Ib RNRs (C), which are the primary subjects of this review.
(A) Active sites of the Fe-containing homoprotocatechuate 2,3-dioxygenase (HPCD) of
Brevibacterium fuscum (white) (PDB code: 1Q0C) and the Mn-containing HPCD (MndD)
of Arthrobacter globiformis (pink, 1F1V), each soaked with homoprotocatechuate
(orange).31 (B) Active sites of the FeSOD (white, 1ISB)32 and MnSOD (pink, 1D5N)33 of
E. coli. (C) Reduced (top) and oxidized (bottom) forms of the class Ia and Ib RNRs. At the
top, the diferrous form of E. coli class Ia RNR (1PIY, white)34 is overlaid with the
dimanganese(II) form of B. subtilis class Ib RNR (4DR0, chain A, pink).35 At the bottom,
the diferric form of E. coli class Ia RNR (1MXR, white)36 is overlaid with the
dimanganese(III) form of C. ammoniagenes class Ib RNR (3MJO, pink).13 Mn ions are
purple spheres, Fe ions are brown spheres, and solvent molecules are red spheres. Metal–
ligand bonds are shown as dotted lines. Figures were generated using PyMOL.
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Fig. 2.
Reactions catalyzed by the enzymes discussed in this review, where M=Mn or Fe. (A)
Ribulose 5-phosphate 3-epimerase (Rpe) catalyzes the reversible interconversion of ribulose
5-phosphate and xylulose 5-phosphate. (B) A representative of the extradiol dioxygenases,
homoprotocatechuate 2,3-dioxygenases catalyze the oxidation of homo-protocatechuate to
2-hydroxy-5-carboxymethylmuconate semialdehyde. (C) Superoxide dismutases (SODs)
catalyze the disproportionation of O2•− to O2 and H2O2. (D) Ribonucleotide reductases
(RNRs) catalyze the conversion of nucleoside 5′-diphosphates (NDPs) to deoxynucleoside
5′-diphosphates (dNDPs). The class I RNRs use two dimeric subunits, α2 and β2, in a 1 : 1
complex; only one monomer is shown here. The β2 subunit contains the metallocofactor and
the α2 subunit contains the site of nucleotide reduction. Upon binding of substrate (NDP,
shown) and nucleotide effector (not shown) to α2, Y• oxidizes a Cys residue in the α2 active
site to a thiyl radical (S•), which initiates nucleotide reduction. Here we show the reaction of
a class Ia RNR (M=Fe). The reactions of the class Ib and Ic RNRs are similar, with
differences related to their distinct cofactors. In the class Ib RNRs (M = Mn), either O2•− or
HOO(H) (not yet determined) is the oxidant in cofactor assembly. In the class Ic RNRs, the
tyrosine shown for the class Ia and Ib RNRs is replaced by a redox-inert residue (Phe in C.
trachomatis RNR) and the active enzyme employs a MnIVFeIII cofactor in the β subunit.
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Fig. 3.
Model for the interrelation of oxidative stress and Fe limitation in expression of the class Ib
RNR in E. coli. In this proposal, H2O2 can inactivate Lewis acid-requiring enzymes that
utilize FeII in catalysis by oxidizing FeII to FeIII, which irreversibly dissociates (as a result of
ligand modification, for example).15,25 Fur is also inactivated, presumably by a similar
mechanism.64 Loss of Fe from Fur activates transcription of Fur-repressed genes such as
mntH and nrdHIEF, mimicking general Fe limitation.65,66 H2O2 also induces, via OxyR,67
expression of MntH and the ferritin-like protein Dps. Dps sequesters free iron using H2O2 as
an oxidant. MntH imports MnII. H2O2 leads to increased levels of the apo form of IscR, by
destroying the [2Fe2S] cluster of IscR (shown here) and/or by interfering with its assembly
(as proposed by Imlay68); apo-IscR positively regulates nrdHIEF transcription.66 Together,
MnII import and FeII oxidation and sequestration leads to NrdF being metallated with MnII,
with the essential oxidant for cluster assembly provided by NrdI’s reaction with O2.12
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Fig. 4.
Classes of RNRs. RNRs are classified on the basis of the metallocofactor used to reversibly
generate the cysteine thiyl radical (red) essential for catalysis. Class Ia RNRs use a diferric-
Y• cofactor, class Ib RNRs use a dimanganese(III)-Y• cofactor, class Ic RNRs use a
MnIVFeIII cofactor, class II RNRs use adenosylcobalamin, and class III RNRs use a glycyl
radical generated by an activating enzyme requiring S-adenosylmethionine and a [4Fe4S]+
cluster.
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Fig. 5.
General mechanisms of assembly of the metallocofactors of the class I RNRs. Two proposed
mechanisms for MnIII 2-Y• cofactor assembly in class Ib RNRs are shown.12,13,30 The
identities of the bridging ligands are only definitively established for the class Ia RNRs.
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Fig. 6.
The proposed oxidant access route for MnIII 2-Y• cofactor assembly in the E. coli class Ib
RNR complex of NrdI (green) and NrdF (gray) (PDB code: 3N3A). Water molecules in the
channel connecting the FMN cofactor (yellow) of NrdI and the MnII 2 site (purple spheres)
of NrdF are shown in blue spheres and mesh, and the highly conserved hydrophilic residues
from NrdI and NrdF lining the channel are indicated.
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Fig. 7.
The importance of accessory factors in metallation and assembly of the E. coli class Ia and
Ib RNR metallocofactors. The structural images were created in PyMOL from the crystal
structures of E. coli FeIII 2–NrdB (1MXR), C. ammoniagenes MnIII 2–NrdF (3MJO), and S.
Typhimurium FeIII 2–NrdF (2R2F).
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